25 Sep 2025 | 5 Mins Read
Quadria considers sale of Encube, also keeping IPO option on table
Flipitmoney
Quadria Capital is pursuing a dual-track process to sell its stake in Indian dermatology firm Encube Ethicals, seeking a $2.2 billion valuation. Buyout firms KKR, Blackstone, and EQT have shown interest in acquiring a controlling stake, while an IPO is also being explored. JP Morgan is involved in the process, with merchant bankers yet to be appointed.